glucose uptake: nootropics and compounds | sci-wiki

Insulin Aspart

Insulin aspart is a rapid-acting insulin analog used to control blood sugar in people with type 1 and type 2 diabetes. It is a laboratory-modified form of human insulin in which the amino acid proline at position B28 is replaced by aspartic acid, a change that makes the insulin absorb and act more quickly than regular human insulin. Developed by Novo Nordisk and sold under names such as NovoLog and NovoRapid, it is taken at mealtimes and is listed by the World Health Organization as an essential medicine.

1 outlet

Insulin

Insulin Glargine

Insulin glargine is a long-acting, or basal, insulin analog used to provide a steady background level of insulin in people with type 1 and type 2 diabetes. It is a modified human insulin engineered to dissolve slowly after injection, releasing insulin at a relatively flat rate over roughly a day so that a single daily dose can cover the body's baseline needs. First approved in 2000 and originally sold as Lantus, it is now available in several brands and biosimilars and appears on the World Health Organization list of essential medicines.

1 outlet

Insulin

Insulin Human (30/70 Biphasic)

Biphasic human insulin 30/70 is a premixed insulin that combines a short-acting and an intermediate-acting insulin in a single fixed formulation, containing 30 percent soluble regular human insulin and 70 percent protamine-bound isophane (NPH) insulin. This blend delivers both a mealtime and a background insulin effect from one injection, which is why it is often used in type 2 diabetes to simplify treatment. It is a cloudy suspension given once or twice daily and is a long-established, widely used insulin preparation.

2 outlets

Insulin

Insulin Human (Regular)

Regular insulin, also called soluble or short-acting insulin, is human insulin with its natural, unmodified amino acid sequence, used to lower blood sugar in diabetes. Given by injection before meals or into a vein in the hospital, it begins working in about half an hour and lasts several hours, and it is a standard treatment for diabetic emergencies such as ketoacidosis and for dangerously high blood potassium. Modern regular insulin is produced by recombinant DNA technology, and it appears on the World Health Organization list of essential medicines.

2 outlets

Insulin

Insulin Lispro

Insulin lispro is a rapid-acting insulin analog used at mealtimes to control blood sugar in type 1 and type 2 diabetes. It was the first insulin analog to be developed, created by swapping the order of two amino acids, lysine and proline, near the end of the insulin B chain so that the hormone is absorbed and acts faster than regular human insulin. Introduced by Eli Lilly in 1996 under the brand name Humalog, it is listed by the World Health Organization as an essential medicine.

1 outlet